Physician profile
Sierra Eames
NPI 1609561521
$2,374.36
in general payments reported to CMS, 2019-2025
15 companies · $650 in 2025
The $650 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $713 · 2024: $1,012 · 2025: $650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,374.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $740.59 | 2023-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $637.97 | 2023-2025 | Lifevest |
| Abbott Laboratories | $337.57 | 2023-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Aveir |
| Bard Peripheral Vascular, INC. | $152.00 | 2025 | Venclose Maven Catheter |
| Silk Road Medical, INC. | $111.79 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Astrazeneca Pharmaceuticals Lp | $95.05 | 2024 | Lokelma |
| Kestra Medical Technology Services, INC. | $78.45 | 2025 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.44 | 2023 | Jardiance |
| Kiniksa Pharmaceuticals International, Plc | $42.81 | 2024 | Arcalyst |
| Pfizer INC. | $29.78 | 2024 | |
| Boston Scientific Corporation | $21.44 | 2023 | Lux-Dx Insertable Cardiac Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $19.24 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $17.15 | 2023 | Inpefa |
| Amgen INC. | $16.04 | 2025 | Repatha |
| Novartis Pharmaceuticals Corporation | $13.04 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sierra Eames listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.